BR9908278A - Uso de agentes de melhoria de penetração e de rompimento de barreiras da pele, melhorar a resposta transcutânea imune induzida pela etoxina de ribosilatação de adp - Google Patents
Uso de agentes de melhoria de penetração e de rompimento de barreiras da pele, melhorar a resposta transcutânea imune induzida pela etoxina de ribosilatação de adpInfo
- Publication number
- BR9908278A BR9908278A BR9908278-0A BR9908278A BR9908278A BR 9908278 A BR9908278 A BR 9908278A BR 9908278 A BR9908278 A BR 9908278A BR 9908278 A BR9908278 A BR 9908278A
- Authority
- BR
- Brazil
- Prior art keywords
- improve
- transcutaneous
- immune
- agents
- penetration
- Prior art date
Links
- 230000035515 penetration Effects 0.000 title abstract 3
- 230000004044 response Effects 0.000 title abstract 2
- 230000005730 ADP ribosylation Effects 0.000 title 1
- 230000008591 skin barrier function Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 abstract 1
- 230000005875 antibody response Effects 0.000 abstract 1
- 239000013043 chemical agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002095 exotoxin Substances 0.000 abstract 1
- 231100000776 exotoxin Toxicity 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: "USO DE AGENTES DE MELHORIA DE PENETRAçãO E DE ROMPIMENTO DE BARREIRAS DA PELE, PARA MELHORAR A RESPOSTA TRANSCUTâNEA IMUNE INDUZIDA PELA EXOTOXINA DE RIBOSILATAçãO DE ADP". A presente invenção compreende um sistema de imunização transcutânea, em que a aplicação tópica de um coadjuvante e de um antígeno ou de ácido nucléico codificador de um antígeno à pele intacta, induz uma resposta de anticorpo sistêmica ou mucosal. A resposta imune assim deduzida, pode ser melhorada através de agentes físicos ou químicos que melhoram a penetração na pele.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7585098P | 1998-02-25 | 1998-02-25 | |
US7585698P | 1998-02-25 | 1998-02-25 | |
PCT/US1999/004128 WO1999043350A1 (en) | 1998-02-25 | 1999-02-25 | Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9908278A true BR9908278A (pt) | 2002-01-02 |
Family
ID=26757358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9908278-0A BR9908278A (pt) | 1998-02-25 | 1999-02-25 | Uso de agentes de melhoria de penetração e de rompimento de barreiras da pele, melhorar a resposta transcutânea imune induzida pela etoxina de ribosilatação de adp |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP1061951B1 (pt) |
JP (2) | JP4875799B2 (pt) |
AT (2) | ATE365050T1 (pt) |
AU (1) | AU3311599A (pt) |
BR (1) | BR9908278A (pt) |
CA (1) | CA2321596C (pt) |
DE (2) | DE69910743T2 (pt) |
ES (1) | ES2289200T3 (pt) |
WO (1) | WO1999043350A1 (pt) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
EP1486215A3 (en) * | 1997-03-21 | 2006-04-12 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
JP4932086B2 (ja) * | 1999-04-08 | 2012-05-16 | インターセル ユーエスエイ、インコーポレイテッド | 経皮的免疫のための乾燥製剤 |
US20030078499A1 (en) | 1999-08-12 | 2003-04-24 | Eppstein Jonathan A. | Microporation of tissue for delivery of bioactive agents |
US6835184B1 (en) | 1999-09-24 | 2004-12-28 | Becton, Dickinson And Company | Method and device for abrading skin |
US8465468B1 (en) | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
US7030228B1 (en) | 1999-11-15 | 2006-04-18 | Miltenyi Biotec Gmbh | Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
US6595947B1 (en) | 2000-05-22 | 2003-07-22 | Becton, Dickinson And Company | Topical delivery of vaccines |
GB0017999D0 (en) | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
AU2002250071B2 (en) * | 2001-02-13 | 2008-02-14 | Government Of The United States, As Represented By The Secretary Of The Army | Vaccine for transcutaneous immunization |
AU2002252378B2 (en) | 2001-03-19 | 2007-10-18 | Intercell Usa, Inc. | Transcutaneous immunostimulation |
CN1516595A (zh) * | 2001-03-19 | 2004-07-28 | Iomai公司 | 用于经皮免疫的贴剂 |
ATE440617T1 (de) * | 2001-05-23 | 2009-09-15 | Duotol Ab | Unterdrückung von allergischen reaktionen durch transkutane verabreichung von allergenen zusammen mit oder fusioniert mit toxinuntereinheiten oder deren fragmenten |
JP2004532698A (ja) | 2001-06-08 | 2004-10-28 | ベクトン・ディキンソン・アンド・カンパニー | ニードルまたはアブレーダーアレイの操作のための装置 |
ATE471990T1 (de) | 2001-08-13 | 2010-07-15 | Univ Rochester | Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln |
WO2003052117A2 (en) * | 2001-09-19 | 2003-06-26 | Massachusetts Institute Of Technology | Methods and products related to non-viral transfection |
US9918665B2 (en) | 2002-03-11 | 2018-03-20 | Nitto Denko Corporation | Transdermal porator and patch system and method for using same |
US7392080B2 (en) | 2002-03-11 | 2008-06-24 | Altea Therapeutics Corporation | Transdermal drug delivery patch system, method of making same and method of using same |
CN1655834A (zh) | 2002-05-06 | 2005-08-17 | 贝克顿·迪金森公司 | 用于控制药代动力学的方法和装置 |
US20040009180A1 (en) * | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
EP1545605B8 (en) * | 2002-10-02 | 2010-05-26 | Nordic Vaccine A/S | Composition for vaccination |
US7196186B2 (en) | 2003-01-15 | 2007-03-27 | Research Institute For Genetic And Human Therapy (R.I.G.H.T.) | DNA composition and uses thereof |
US8016811B2 (en) | 2003-10-24 | 2011-09-13 | Altea Therapeutics Corporation | Method for transdermal delivery of permeant substances |
EP1708744A4 (en) * | 2003-12-09 | 2009-07-15 | Intercell Usa Inc | GM1 Binding Dereficent Exotoxins for Use as Immunoinguarantees |
US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
CA3031270A1 (en) * | 2004-03-03 | 2005-12-22 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
EP1861112A4 (en) | 2005-03-03 | 2009-07-22 | Revance Therapeutics Inc | COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS |
CN101242869B (zh) | 2005-09-02 | 2010-05-26 | Iomai公司 | 经皮递送疫苗和透皮递送药物的装置及其应用 |
JP5186678B2 (ja) * | 2005-10-13 | 2013-04-17 | 財団法人ヒューマンサイエンス振興財団 | 経皮抗原投与のための抗原キット |
US20110223197A1 (en) | 2005-10-18 | 2011-09-15 | Novartis Vaccines And Diagnostics Inc. | Mucosal and Systemic Immunization with Alphavirus Replicon Particles |
FR2924349B1 (fr) | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
EP2305292A4 (en) | 2008-08-01 | 2013-02-20 | So Pharmaceutical Corp | TRANSDERMAL IMMUNIZER OF S / O TYPE |
DE102011018499A1 (de) | 2011-04-23 | 2012-10-25 | Emc Microcollections Gmbh | Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut |
WO2014044690A1 (en) | 2012-09-18 | 2014-03-27 | Valneva Austria Gmbh | Improved vaccines |
EP3189854B1 (en) | 2014-09-03 | 2020-04-29 | Nitto Denko Corporation | Vaccine composition for transdermal or transmucosal administration |
KR20220147278A (ko) | 2021-04-27 | 2022-11-03 | (주)아모레퍼시픽 | 리포푸신 축적 억제 또는 리포푸신 제거용 조성물 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4810499A (en) * | 1984-10-01 | 1989-03-07 | Biotek, Inc. | Transdermal drug delivery system and method |
JPS6468327A (en) * | 1987-09-08 | 1989-03-14 | Teisan Seiyaku Kk | Warming type insulin-containing plaster |
GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
JPH0679002A (ja) * | 1993-12-14 | 1994-03-22 | Hisamitsu Pharmaceut Co Inc | 経皮投与用パッチシステム |
US5989586A (en) * | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
US5679647A (en) * | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
JPH07304690A (ja) * | 1994-05-13 | 1995-11-21 | Advanced Sukin Res Kenkyusho:Kk | 角質溶解剤、経皮吸収促進剤及び皮膚外用製剤 |
JP2701005B2 (ja) * | 1994-09-07 | 1998-01-21 | 株式会社林原生物化学研究所 | 減感作剤 |
JPH0912448A (ja) * | 1995-04-28 | 1997-01-14 | Read Chem Kk | 薬物放出制御型経皮吸収製剤 |
AU5869796A (en) * | 1995-05-22 | 1996-12-11 | Ned A. Godshall | Micromechanical patch for enhancing the delivery of compound s through the skin |
JPH09124468A (ja) * | 1995-10-27 | 1997-05-13 | Nippon Zoki Pharmaceut Co Ltd | 薬剤内包外皮用貼付剤 |
CO4600681A1 (es) * | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
JPH1025243A (ja) * | 1996-07-09 | 1998-01-27 | Showa Denko Kk | 鎮痛消炎外用貼付剤 |
US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
-
1999
- 1999-02-25 EP EP99936034A patent/EP1061951B1/en not_active Expired - Lifetime
- 1999-02-25 BR BR9908278-0A patent/BR9908278A/pt not_active Application Discontinuation
- 1999-02-25 CA CA2321596A patent/CA2321596C/en not_active Expired - Fee Related
- 1999-02-25 AT AT03007948T patent/ATE365050T1/de active
- 1999-02-25 EP EP10012335A patent/EP2286834A3/en not_active Withdrawn
- 1999-02-25 JP JP2000533145A patent/JP4875799B2/ja not_active Expired - Fee Related
- 1999-02-25 DE DE69910743T patent/DE69910743T2/de not_active Expired - Lifetime
- 1999-02-25 ES ES03007948T patent/ES2289200T3/es not_active Expired - Lifetime
- 1999-02-25 WO PCT/US1999/004128 patent/WO1999043350A1/en active IP Right Grant
- 1999-02-25 AU AU33115/99A patent/AU3311599A/en not_active Abandoned
- 1999-02-25 AT AT99936034T patent/ATE247979T1/de not_active IP Right Cessation
- 1999-02-25 DE DE69936355T patent/DE69936355T2/de not_active Expired - Lifetime
-
2011
- 2011-10-13 JP JP2011225680A patent/JP2012041355A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1999043350A1 (en) | 1999-09-02 |
ES2289200T3 (es) | 2008-02-01 |
DE69936355T2 (de) | 2008-02-21 |
EP1061951A1 (en) | 2000-12-27 |
DE69936355D1 (de) | 2007-08-02 |
EP2286834A3 (en) | 2012-01-25 |
DE69910743D1 (de) | 2003-10-02 |
JP2012041355A (ja) | 2012-03-01 |
AU3311599A (en) | 1999-09-15 |
JP4875799B2 (ja) | 2012-02-15 |
ATE247979T1 (de) | 2003-09-15 |
CA2321596C (en) | 2012-05-29 |
EP2286834A2 (en) | 2011-02-23 |
EP1061951B1 (en) | 2003-08-27 |
ATE365050T1 (de) | 2007-07-15 |
CA2321596A1 (en) | 1999-09-02 |
JP2002504522A (ja) | 2002-02-12 |
DE69910743T2 (de) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9908278A (pt) | Uso de agentes de melhoria de penetração e de rompimento de barreiras da pele, melhorar a resposta transcutânea imune induzida pela etoxina de ribosilatação de adp | |
BRPI0208301A8 (pt) | vacinas de ácido nucléico para prevenção de infecção por flavivírus | |
IT8722185A0 (it) | Codice di identificazione rilevabile magneticamente per contrassegnare prodotti, documenti e simili. | |
BR9712952A (pt) | Adjuvante para imunização transcutânea | |
BRPI0408167A (pt) | conjugados de polissacarìdeo-proteìna veìculo adesina da superfìcie estafilocócica para imunização contra infecções nosocomiais | |
BRPI0009163B8 (pt) | composição imunogênica e vacina que a compreende | |
CY1106876T1 (el) | Συσκευασια και μεθοδος ανιχνευσεως της πρωτεϊνης esm-1 | |
BR0203791B1 (pt) | mÉtodo de operar um sistema, sistema e dispositivo de controle para comandar um sistema para o transporte de pessoas/bens em instalaÇÕes de elevador ou em escadas rolantes | |
DK1326636T3 (da) | Vaccinesammensætning | |
MX9401225A (es) | Composicion de vacuna para prevenir la infeccion con influenza en humanos y metodo para su preparacion. | |
BR9906660A (pt) | Processo para medir vìrus da hepatite c | |
ATE457318T1 (de) | Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper | |
Robbins et al. | A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine | |
BRPI0408878A (pt) | sistema e método para controle de insetos | |
Jolie et al. | Antigenic differences within Actinobacillus pleuropneumoniae serotype 1 | |
DK1334196T3 (da) | Genomisk fragment af Streptococcus suis og kliniske anvendelser deraf | |
BR8900697A (pt) | Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto | |
EP1356823A3 (en) | Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response induced by ADP-ribosylating exotoxin | |
BR0013574A (pt) | Antìgeno vacina de moraxella | |
FR2701710B1 (fr) | Conjugués protéiques, compositions les contenant et leurs applications en tant que médicament et réactif de diagnostic. | |
Hassl et al. | Detection and characterization of circulating antigens in acute experimental infections of mice with four different strains of Toxoplasma gondii | |
BR0208588A (pt) | Antìgenos para despertar uma resposta imune contra patógenos de ehrilichieae e rickettsieae | |
Pyne et al. | Speed on rural arterial roads | |
KR920021163A (ko) | 비-자극성 백신 조성물 | |
KR960037749A (ko) | 유해전자파 중화교환기 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved | ||
B25A | Requested transfer of rights approved |
Free format text: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11 E 25 DA LPI. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] |